Representative before the EPO

Employment test 51 - 200 employees
Company dna reddie and grose llp
operating since 1907
Headquarter in London and 2 offices
active in Legal Services, IP Consulting, and IP Portfolio Processing

We have observed 2 EP applications Matthew Train has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after September 20, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP13180005

Novel triazinedione derivatives as GABA-B receptor modulators

IPC classification:
A61P 25/00, A61K 31/53, C07D 253/075, C07D 491/04, C07D 417/12, C07D 417/06, C07D 413/10, C07D 413/06, C07D 409/06, C07D 405/10, C07D 405/06, C07D 403/10, C07D 403/06, C07D 401/06
Agent:
Matthew Train, Reddie & Grose LLP
Status:
EXAMINATION IN PROGRESS
EP13174442

Locating device for needle insertion

IPC classification:
A61M 16/04, A61M 5/42, A61B 17/34
Agent:
Matthew Train, Reddie & Grose LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN

Please Sign in to use this feature